Press enter to begin your search

ValiRx - Strategy Update

VAL
Wed, 08 Jul 2020, 15:15 BST

Dr Suzy Dilly, Chief Executive Officer and Kevin Cox, Chairman of ValiRx, provide an update on the strategic direction of the company. Going forward ValiRx intends to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health. The Company plans to apply both intellectual and financial resources to each project and enable acceleration through pre-clinical development.

Dr Suzanne Dilly
Chief Executive Officer
VAL
Dr Kevin Cox
Non-Executive Chairman
VAL
5f042b7a4e934f0a0e3eba3d
SHOW MORE
FROM THIS COMPANY
ValiRx - Strategy Update
VAL Wed, 08 Jul 2020, 15:15 BST

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Industry: Health Care

Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/

Dr Suzy Dilly, Chief Executive Officer and Kevin Cox, Chairman of ValiRx, provide an update on the strategic direction of the company. Going forward ValiRx intends to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health. The Company plans to apply both intellectual and financial resources to each project and enable acceleration through pre-clinical development.

Dr Suzanne Dilly
Chief Executive Officer
Dr Kevin Cox
Non-Executive Chairman
POWERED BY